Lori Styles

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia

Jan A. Burger, Alessandra Tedeschi, Paul M. Barr et al. · New England Journal of Medicine · 2015 · 1.6K citations · Full text

Medicine, Oncology, Pharmacotherapy +11

Acute Chest Syndrome in Sickle Cell Disease: Clinical Presentation and Course

Elliott Vichinsky, Lori Styles, Linda H. Colangelo et al. · Blood · 1997 · 568 citations · Full text

Medicine, Cardiology, Hematology +9

Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial

Carol Moreno, Richard Greil, Fatih Demırkan et al. · The Lancet Oncology · 2018 · 548 citations

Medicine, Oncology, Pharmacology +13

Ibrutinib for chronic graft-versus-host disease after failure of prior therapy

David B. Miklos, Corey Cutler, Mukta Arora et al. · Blood · 2017 · 499 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +11

Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials

Jennifer R. Brown, Javid J. Moslehi, Susan O’Brien et al. · Haematologica · 2017 · 258 citations · Full text

Medicine, Oncology, Pharmacology +15